Why trust and read this report? No one would have believed us if last Christmas we would have said that during April & May 2020 a devastating pandemic would kill every 10 days 58,000 people, as much as the total number of Americans killed during the ten-year Vietnam war.
New York, June 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Pandemic Mitigation Products Market - 2020-2024" - https://www.reportlinker.com/p05915389/?utm_source=GNW
It devastated the global economy and created an unpredicted mega market.
As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products purchases. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies.
The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.
We found that this virus has created a new market worth $251-$459 Billion* per annum – the COVID-19 Pandemic Mitigation Products and Services market. To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:
Optimistic scenario – assumes (among other things) that mass vaccination will commence by July 2021
Conservative scenario – assumes (among other things) that no mass vaccination will be available until 2025
According to the COVID-19 Pandemic Mitigation Products Market – 2020-2024 report scenarios, the 2020-2024 cumulative market size is expected to be $1.4-$1.9 Trillion. The U.S. and Chinese markets will dominate the global one during the forecast period.
The 2024 COVID-19 Pandemic Mitigation Products Market (Scenario A), by Region
This 1020-page 5 volume market report is the first and most comprehensive review of the global COVID-19 Pandemic Mitigation Products & Services market available today. The objective of this report is to provide today’s strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market.
The COVID-19 Pandemic Mitigation Products Market – 2020-2024 report presents a thorough market analysis of 54 products & services, 6 vertical, 4 revenue source, 5 regional and 13 national markets. Furthermore, the report provides updated extensive data of 37 key vendors.
As countries start to re-open, and you do your best to recover your business, the report brings to your attention multi-billion business opportunities that may assist your struggle to retain business continuity and growth. This newly formed market is not limited to the healthcare supplier’s industry; many business opportunities are being created for industries from geo-surveillance to blockchain, from AI, big-data & deep learning to nonwoven fabrics.
Why Buy this Homeland Security Market Report?
A. Questions answered in this report include:
What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecasted trends during 2020-2024?
What are the most attractive business opportunities?
What drives the customers to purchase solutions and services?
What are the COVID-19 Mitigation technology & services trends?
What is the 212 sub-markets size over the 2020-2024 period?
What are the challenges to market penetration & growth?
B. The COVID-19 Pandemic Mitigation Products Market size data is analyzed via 5 independent key perspectives.
With a highly fragmented market we address the “money trail” – each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:
By 54 Products and Services:
Other COVID-19 Pharma Industry Products
PCR Instrumentation & Software
Robotic PCR Systems & Software
PCR Reagents & Consumables
Nose & Mouth Swabs
Self-collection PCR Test Kits
Serologic Test Kits
FDG-PET/CT Procedures & Wastewater Testing
PACS & Teleradiology
Medical PPE Gowns
Medical Face Masks
Medical Face Shields
Medical Eye Protection
PPE Sterilization: Systems & Consumables
Hand & Surface Sanitizers
Other Personal Protection Gear
AI, Big Data & Deep Learning
Geo-Surveillance Systems & Services
Invasive Mechanical Ventilators
Next Generation Ventilators
COVID-19 Homecare (HW, SW, Services)
Surge Capacity Hospitals & ICUs
Extracorporeal Membrane Oxygenation Procedures
Other Intensive Care Modalities
PPE Gowns Manufacturing Plants
Gloves Manufacturing Plants
Face Masks Manufacturing Plants
Face Shields Manufacturing Plants
Serologic Test Kits Manufacturing Plants
Melt-Blown PPE Fabric Manufacturing Plants
Spun-Bond PPE Fabric Manufacturing Plants
Self-collection PCR Test Kits Manufacturing Plants
Ventilators Manufacturing Plants
PCR Reagents Manufacturing Plants
PCR Systems Manufacturing Plants
Nose & Mouth Swabs Manufacturing Plants
Medical Glass & Other Manufacturing Plants
R&D Equipment & Consumables
Medical Glass and Other Products & Services
By 6 Vertical Market:
Hospitals and Surge Hospitals
Emergency Medical Services (EMS)
Homecare & Nursing Homes
By 13 National Markets:
Rest of Europe
Rest of Asia Pacific
By 5 Regional Markets:
Middle East & Africa
By 4 Revenue Source Markets:
Planning & Consulting
Maintenance & Upgrades
C. Detailed market analysis frameworks for each of the market sectors are provided, including:
Market drivers & inhibitors
Competitive analysis for each of the 54 products and services that covers:
Barriers to Entry
Barriers to Substitution.
The 2020-2024 market segmented into 212 submarkets
D. The report provides an updated extensive data of the leading 37 companies (including companies’ profile, recent annual revenues, COVID-19 mitigation activities & products and contact information).
E. The report includes over 2300 links to the COVID-19 Pandemic Mitigation community information sources
F. The report mentions > 450 Vendors including the following:
3M Company, 3Scan, Abbott , AbCellera, Advenio Technosys, Agfa Healthcare, Agilent Technologies, AiCure, Aindra, Allscripts Healthcare Solutions, Amara Health Analytics , Amazon , analyticsMD, Apixio, Apple, Arterys Inc, Atlas Wearables, Atomwise, Avalon Nutrition VITL, Babylon Health, Bay Labs, Behold.ai, benevolent.ai, BIOBEATS, BlueDot, Bollé Safety, Bullard, Buoy Health, Care Angel Wearables QorQL, Careskore, Clinithink, Cloud Pharmaceuticals, CloudMedx, CureMetrix Mental health Ginger.io, Cyrcadia, Deep 6 AI, Deep Genomics, Dell Technologies Inc., Delta Plus Group, Desktop Genetics Virtual mate Ada Health, DreaMed Diabetes, Dupont, EaglEyeMed, Eli Lilly, Encon Safety Products, Enlitic, EnsoData, Entopsis, Envisagenics Research iCarbonX, ERB Industries Inc., Ergodyne, Essilor of America, Flashback Technologies, Flow Health, Ford, Freenome, Frequency Therapeutics Inc., Fujifilm Holdings Corporation, Gateway Safety Inc., GE Healthcare, General Electric, General Motors, General Vision, Gentex Corporation, Gibco, Gilead Sciences, Globavir Biosciences, Google, Healint, Health Fidelity, HealthNextGen, HexArmor, Hindsait, Honeywell Safety Products, IBM, Imagen Technologies, Imagia Cybernetics, Infermedica, Infervision, Inovio Pharmaceuticals, Inside DNA, InSilico Medicine, Intel Corporation, Intendu, Invitrogen, Ion Torrent, Ironwear, Johnson & Johnson (Janssen), Jvion, Kapa Biosystems, Keen Eye Technologies, Kimberly-Clark Professional, Koninklijke Philips NV, Lexmark International Inc., LifeGraph, Lucina Health, Lumiata, Lunit, Lytics, Magnea, Maxim Biotech, Maxwell MRI, McKesson Corporation, MCR Safety, Medal, Medalogix, Medasense, MedAware, Medtronic, MedWhat, MedyMatch , Merck, Metabiota, Micron Technology, Microsoft Corporation, Mindshare Medical, Moderna, Morpheo, Niramai Health Analytix, Novarad Corporation, NuMedii, Numerate, Nuritas Pharma Turbine, Nvidia Corporation, Oncora Medical, Ovuline, PeerWell, Pfizer, Philips, Philips Healthcare, PhysIQ., Precision Health Intelligence, Predible Health, Profility, Proscia, pulseData, Pyramex Safety, Qualaris Healthcare Solutions, Qualcomm Incorporated, Qualcomm Incorporated, Qure. Ai, Radians Inc., Recursion Pharmaceuticals, Regeneron Pharmaceuticals, Roam Analytics , Roche, RxPREDICT, Safety Optical Service, Samsung Electronics Co., Ltd, Sanofi, Saykara, Sellstrom Manufacturing Company (SureWerx), Sense.ly, Sensory Inc., Siemens, Sigma-Aldrich Corp., Skymind Inc., Thermo Fisher Scientific, Toshiba, Vir Biotechnology Inc., VisionAid Inc., WuXi Biologics, Xilinx Inc..
G. COVID-19 Pandemic Mitigation Products & Services Market report includes 24 appendices:
Appendix 1: Differences & Similarities Between Common Flu and Coronavirus
Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel
Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection
Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns
Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks
Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators
Appendix 7: CDC Adult Vaccine Price List
Appendix 8: The CDC COVID-19 Bio-Safety Guidelines
Appendix 9: The 2020 Global Desperation to Protect Medical Workers
Appendix 10: Disinfection Procedures for COVID-19
Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020
Appendix 12: European Preparedness Against Emerging Epidemics
Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19
Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization
Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)
Appendix 16: Comparing Clinical COVID-19 Data by Nation
Appendix 17: Home Healthcare IT
Appendix 18: The Difference between PCR and Antibody Tests
Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021
Appendix 20: COVID-19 Tests
Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region
Appendix 22: Abbreviations
Appendix 23: Glossary
Appendix 24: Bibliography
Read the full report: https://www.reportlinker.com/p05915389/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Intl: +1 339-368-6001